14,800 Shares in Maximus, Inc. $MMS Purchased by VIRGINIA RETIREMENT SYSTEMS ET Al

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Maximus, Inc. (NYSE:MMS) during the second quarter, HoldingsChannel reports. The fund purchased 14,800 shares of the health services provider’s stock, valued at approximately $1,039,000.

Several other hedge funds have also recently bought and sold shares of the company. LRI Investments LLC increased its holdings in Maximus by 11.9% in the 1st quarter. LRI Investments LLC now owns 1,833 shares of the health services provider’s stock valued at $125,000 after buying an additional 195 shares during the period. Verus Financial Partners Inc. increased its holdings in Maximus by 6.7% in the 2nd quarter. Verus Financial Partners Inc. now owns 3,387 shares of the health services provider’s stock valued at $244,000 after buying an additional 214 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Maximus by 0.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after buying an additional 221 shares during the period. Vestcor Inc increased its holdings in Maximus by 2.3% in the 1st quarter. Vestcor Inc now owns 9,877 shares of the health services provider’s stock valued at $674,000 after buying an additional 223 shares during the period. Finally, UMB Bank n.a. boosted its stake in shares of Maximus by 37.5% in the 2nd quarter. UMB Bank n.a. now owns 833 shares of the health services provider’s stock valued at $58,000 after purchasing an additional 227 shares in the last quarter. 97.21% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on MMS. Weiss Ratings upgraded shares of Maximus from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, October 8th. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating and two have given a Buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $90.00.

Maximus Stock Up 0.2%

Maximus stock opened at $87.72 on Friday. The company has a debt-to-equity ratio of 0.91, a quick ratio of 2.27 and a current ratio of 2.27. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.73. The firm has a 50 day moving average price of $87.75 and a two-hundred day moving average price of $77.17. The firm has a market cap of $4.94 billion, a price-to-earnings ratio of 16.15 and a beta of 0.57.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same quarter last year, the business earned $1.74 EPS. The company’s revenue was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Equities analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 1st. Stockholders of record on Friday, November 14th will be paid a $0.30 dividend. The ex-dividend date is Friday, November 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.4%. Maximus’s payout ratio is currently 22.10%.

Insider Buying and Selling at Maximus

In other news, insider Michelle F. Link sold 1,610 shares of Maximus stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total value of $146,284.60. Following the completion of the sale, the insider owned 13,508 shares in the company, valued at $1,227,336.88. The trade was a 10.65% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is owned by corporate insiders.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.